HAE:TSX
MONTREAL, Jan. 21 /PRNewswire-FirstCall/ - Haemacure Corporation , a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, announces the results of the fiscal year ended October 31, 2008.
CONTACT: Haemacure Corporation: Joseph Galli, Chairman and CEO, (514)
990-7074, jgalli@haemacure.ca; Gilles Lemieux, Secretary, (514) 282-3350,
ext. 22, ir@haemacure.ca; Jason Tuthill, Investor Relations, (914)
980-4776, jtuthill@haemacurecorp.com; www.haemacure.com
